MedTrace Logo

COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)

NCT04416308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9453

Last updated 2023-05-24

No results posted yet for this study

Summary

Since the start of this epidemic, numerous clinical and fundamental studies have been conducted to best adapt the individual management of COVID-19 cases \[1-6\]. In parallel with this work, it is necessary to better understand the characteristics of the epidemic in the general population but also in the population working in healthcare settings more exposed to SARS-CoV-2. Seroprevalence studies are therefore particularly useful in order to understand the collective immunization rate and the factors that can explain this immunization.

Conditions

  • Coronavirus

Interventions

DIAGNOSTIC_TEST

NG test

rapid diagnosis Covid 19

DIAGNOSTIC_TEST

Blood test

sample

BEHAVIORAL

Self-questionnary

behavioral survey

Sponsors & Collaborators

  • Fonds NOMINOE

    collaborator UNKNOWN

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Christophe PARIS, MD · CHU Rennes

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2020-07-10
Completion
2020-10-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04416308 on ClinicalTrials.gov